1. Academic Validation
  2. Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress

Bunyavirus SFTSV exploits autophagic flux for viral assembly and egress

  • Autophagy. 2022 Jul;18(7):1599-1612. doi: 10.1080/15548627.2021.1994296.
Jia-Min Yan 1 Wen-Kang Zhang 1 Li-Na Yan 1 Yong-Jun Jiao 2 Chuan-Min Zhou 1 3 Xue-Jie Yu 1
Affiliations

Affiliations

  • 1 State Key Laboratory of Virology, School of Public Health, Wuhan University, Wuhan, China.
  • 2 Nhc Key laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China, Nanjing, China.
  • 3 Department of Infectious Diseases, Zhongnan Hospital of Wuhan University, Wuhan, China.
Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging negatively stranded enveloped RNA bunyavirus that causes SFTS with a high case fatality rate of up to 30%. Macroautophagy/Autophagy is an evolutionarily conserved process involved in the maintenance of host homeostasis, which exhibits anti-viral or pro-viral responses in reaction to different viral challenges. However, the interaction between the bunyavirus SFTSV and the autophagic process is still largely unclear. By establishing various autophagy-deficient cell lines, we found that SFTSV triggered RB1CC1/FIP200-BECN1-ATG5-dependent classical Autophagy flux. SFTSV nucleoprotein induced BECN1-dependent Autophagy by disrupting the BECN1-BCL2 association. Importantly, SFTSV utilized Autophagy for the viral life cycle, which not only assembled in autophagosomes derived from the ERGIC and Golgi complex, but also utilized autophagic vesicles for exocytosis. Taken together, our results suggest a novel virus-autophagy interaction model in which bunyavirus SFTSV induces classical Autophagy flux for viral assembly and egress processes, suggesting that Autophagy inhibition may be a novel therapy for treating or releasing SFTS.

Keywords

Autophagy; bunyavirus; sftsv; viral assembly; viral egress.

Figures
Products